The study, by Duke-NUS Graduate Medical School in Singapore, found that increased caffeine intake could reduce the disease that affects an estimated 30% of American adults. The analysis will be published in the September issue of Hepatology.
Meanwhile, another recent study detailed in Liver International found that in patients with chronic hepatitis C, coffee consumption was associated with an improved response to antiviral therapy.
This isn’t the first time that coffee’s hit the headlines. Earlier this year, research by Minnesota’s Mayo Clinic found that regular consumption of coffee is associated with a reduced risk of liver disease called primary sclerosing cholangitis.
As always, check with your physician before making any specific changes to your lifestyle.
